EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles

Wen-Hsuan Tsai,1 Kun-Hua Yu,1 Yi-Cheng Huang,2 Cheng-I Lee1 1Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi, Taiwan, Republic of China; 2Department of Food Science, National Taiwan Ocean University, Keelung City, Taiwan, Republic of China Background: Photod...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tsai WH, Yu KH, Huang YC, Lee CI
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/5f2e340657ad4478ab4f1ab86becd16d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f2e340657ad4478ab4f1ab86becd16d
record_format dspace
spelling oai:doaj.org-article:5f2e340657ad4478ab4f1ab86becd16d2021-12-02T05:09:47ZEGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles1178-2013https://doaj.org/article/5f2e340657ad4478ab4f1ab86becd16d2018-02-01T00:00:00Zhttps://www.dovepress.com/egfr-targeted-photodynamic-therapy-by-curcumin-encapsulated-chitosantp-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wen-Hsuan Tsai,1 Kun-Hua Yu,1 Yi-Cheng Huang,2 Cheng-I Lee1 1Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi, Taiwan, Republic of China; 2Department of Food Science, National Taiwan Ocean University, Keelung City, Taiwan, Republic of China Background: Photodynamic therapy (PDT) is an effective therapy for cancers and is a minimally invasive therapy with low dark toxicity and limited side effects. PDT employs the combination of photosensitizers with a specific light source to produce reactive oxygen species (ROS) to damage tumor cells. Methods: We fabricated nanoparticles encapsulating curcumin through crosslinking chitosan and tripolyphosphate (TPP). Additionally, the chitosan was conjugated to epidermal growth factor in order to target the epidermal growth factor receptor (EGFR), overexpressed on cancer cells. To investigate PDT using fabricated nanoparticles, we measured cell viabilities and ROS production in relation to EGFR-overexpressing gastric cancer cells and non-cancer gastric cells.Results: The targeting nanoparticles displayed a superior PDT effect in the cancer cell, with a resultant approximately fourfold decrease in the IC50. The PDT mechanism of curcumin-encapsulated nanoparticles is further identified as the generation of 1O2, the major pathway in PDT.Conclusion: These curcumin-encapsulated chitosan/TPP nanoparticles are a promising targeted-PDT against EGFR-overexpressing cancers. Keywords: EGFR-targeting, cancer, photodynamic therapy, curcumin, chitosan Tsai WHYu KHHuang YCLee CIDove Medical PressarticleEGFR-targetingcancerphotodynamic therapycurcuminchitosanMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 903-916 (2018)
institution DOAJ
collection DOAJ
language EN
topic EGFR-targeting
cancer
photodynamic therapy
curcumin
chitosan
Medicine (General)
R5-920
spellingShingle EGFR-targeting
cancer
photodynamic therapy
curcumin
chitosan
Medicine (General)
R5-920
Tsai WH
Yu KH
Huang YC
Lee CI
EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
description Wen-Hsuan Tsai,1 Kun-Hua Yu,1 Yi-Cheng Huang,2 Cheng-I Lee1 1Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi, Taiwan, Republic of China; 2Department of Food Science, National Taiwan Ocean University, Keelung City, Taiwan, Republic of China Background: Photodynamic therapy (PDT) is an effective therapy for cancers and is a minimally invasive therapy with low dark toxicity and limited side effects. PDT employs the combination of photosensitizers with a specific light source to produce reactive oxygen species (ROS) to damage tumor cells. Methods: We fabricated nanoparticles encapsulating curcumin through crosslinking chitosan and tripolyphosphate (TPP). Additionally, the chitosan was conjugated to epidermal growth factor in order to target the epidermal growth factor receptor (EGFR), overexpressed on cancer cells. To investigate PDT using fabricated nanoparticles, we measured cell viabilities and ROS production in relation to EGFR-overexpressing gastric cancer cells and non-cancer gastric cells.Results: The targeting nanoparticles displayed a superior PDT effect in the cancer cell, with a resultant approximately fourfold decrease in the IC50. The PDT mechanism of curcumin-encapsulated nanoparticles is further identified as the generation of 1O2, the major pathway in PDT.Conclusion: These curcumin-encapsulated chitosan/TPP nanoparticles are a promising targeted-PDT against EGFR-overexpressing cancers. Keywords: EGFR-targeting, cancer, photodynamic therapy, curcumin, chitosan 
format article
author Tsai WH
Yu KH
Huang YC
Lee CI
author_facet Tsai WH
Yu KH
Huang YC
Lee CI
author_sort Tsai WH
title EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
title_short EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
title_full EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
title_fullStr EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
title_full_unstemmed EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
title_sort egfr-targeted photodynamic therapy by curcumin-encapsulated chitosan/tpp nanoparticles
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/5f2e340657ad4478ab4f1ab86becd16d
work_keys_str_mv AT tsaiwh egfrtargetedphotodynamictherapybycurcuminencapsulatedchitosantppnanoparticles
AT yukh egfrtargetedphotodynamictherapybycurcuminencapsulatedchitosantppnanoparticles
AT huangyc egfrtargetedphotodynamictherapybycurcuminencapsulatedchitosantppnanoparticles
AT leeci egfrtargetedphotodynamictherapybycurcuminencapsulatedchitosantppnanoparticles
_version_ 1718400532807155712